{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:06:35Z","timestamp":1791331595770,"version":"4.3.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["20-34-90153"],"award-info":[{"award-number":["20-34-90153"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["20-04-60556"],"award-info":[{"award-number":["20-04-60556"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Evolution of SARS-CoV-2 in immunocompromised hosts may result in novel variants with changed properties. While escape from humoral immunity certainly contributes to intra-host evolution, escape from cellular immunity is poorly understood. Here, we report a case of long-term COVID-19 in an immunocompromised patient with non-Hodgkin\u2019s lymphoma who received treatment with rituximab and lacked neutralizing antibodies. Over the 318 days of the disease, the SARS-CoV-2 genome gained a total of 40 changes, 34 of which were present by the end of the study period. Among the acquired mutations, 12 reduced or prevented the binding of known immunogenic SARS-CoV-2 HLA class I antigens. By experimentally assessing the effect of a subset of the escape mutations, we show that they resulted in a loss of as much as ~1% of effector CD8 T cell response. Our results indicate that CD8 T cell escape represents a major underappreciated contributor to SARS-CoV-2 evolution in humans.<\/jats:p>","DOI":"10.1038\/s41467-022-34033-x","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T12:04:20Z","timestamp":1673352260000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19"],"prefix":"10.1038","volume":"14","author":[{"given":"Oksana V.","family":"Stanevich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4510-559X","authenticated-orcid":false,"given":"Evgeniia I.","family":"Alekseeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0411-9896","authenticated-orcid":false,"given":"Maria","family":"Sergeeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3558-3261","authenticated-orcid":false,"given":"Artem V.","family":"Fadeev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1465-5548","authenticated-orcid":false,"given":"Kseniya S.","family":"Komissarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3495-4393","authenticated-orcid":false,"given":"Anna A.","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9023-4852","authenticated-orcid":false,"given":"Tamara S.","family":"Simakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7750-9652","authenticated-orcid":false,"given":"Kirill A.","family":"Vasilyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Polina","family":"Shurygina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina A.","family":"Stukova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5126-9953","authenticated-orcid":false,"given":"Ksenia R.","family":"Safina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4532-6085","authenticated-orcid":false,"given":"Elena R.","family":"Nabieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2104-1795","authenticated-orcid":false,"given":"Sofya K.","family":"Garushyants","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galya V.","family":"Klink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny A.","family":"Bakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jullia V.","family":"Zabutova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3751-9143","authenticated-orcid":false,"given":"Anastasia N.","family":"Kholodnaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0882-2936","authenticated-orcid":false,"given":"Olga V.","family":"Lukina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina A.","family":"Skorokhod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1492-5939","authenticated-orcid":false,"given":"Viktoria V.","family":"Ryabchikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadezhda V.","family":"Medvedeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry A.","family":"Lioznov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6174-0836","authenticated-orcid":false,"given":"Daria M.","family":"Danilenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0430-790X","authenticated-orcid":false,"given":"Dmitriy M.","family":"Chudakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1733-1255","authenticated-orcid":false,"given":"Andrey B.","family":"Komissarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2334-2751","authenticated-orcid":false,"given":"Georgii A.","family":"Bazykin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"key":"34033_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","volume":"19","author":"WT Harvey","year":"2021","unstructured":"Harvey, W. T. et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol. 19, 409\u2013424 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"34033_CR2","doi-asserted-by":"publisher","unstructured":"Kemp, S. et al. Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation. https:\/\/doi.org\/10.1101\/2020.12.05.20241927 (2020).","DOI":"10.1101\/2020.12.05.20241927"},{"key":"34033_CR3","doi-asserted-by":"publisher","unstructured":"Williamson, M. K. et al. Chronic SARS-CoV-2 infection and viral evolution in a hypogammaglobulinaemic individual. https:\/\/doi.org\/10.1101\/2021.05.31.21257591 (2021).","DOI":"10.1101\/2021.05.31.21257591"},{"key":"34033_CR4","doi-asserted-by":"publisher","unstructured":"Khatamzas, E. et al. Emergence of multiple SARS-CoV-2 mutations in an immunocompromised host. https:\/\/doi.org\/10.1101\/2021.01.10.20248871 (2021).","DOI":"10.1101\/2021.01.10.20248871"},{"key":"34033_CR5","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.cell.2020.10.049","volume":"183","author":"VA Avanzato","year":"2020","unstructured":"Avanzato, V. A. et al. Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer. Cell 183, 1901\u20131912.e9 (2020).","journal-title":"Cell"},{"key":"34033_CR6","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1056\/NEJMc2031364","volume":"383","author":"B Choi","year":"2020","unstructured":"Choi, B. et al. Persistence and evolution of SARS-CoV-2 in an immunocompromised host. N. Engl. J. Med. 383, 2291\u20132293 (2020).","journal-title":"N. Engl. J. Med."},{"key":"34033_CR7","doi-asserted-by":"publisher","unstructured":"Sepulcri, C. et al. The longest persistence of viable SARS-CoV-2 with recurrence of viremia and relapsing symptomatic COVID-19 in an immunocompromised patient \u2013 a case study. https:\/\/doi.org\/10.1101\/2021.01.23.21249554 (2021).","DOI":"10.1101\/2021.01.23.21249554"},{"key":"34033_CR8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jiac.2020.12.001","volume":"27","author":"Y Nakajima","year":"2021","unstructured":"Nakajima, Y. et al. Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient. J. Infect. Chemother. 27, 387\u2013389 (2021).","journal-title":"J. Infect. Chemother."},{"key":"34033_CR9","doi-asserted-by":"crossref","unstructured":"Moore, J. L., Ganapathiraju, P. V., Kurtz, C. P. & Wainscoat, B. A 63-year-old woman with a history of non-Hodgkin lymphoma with persistent SARS-CoV-2 infection who was seronegative and treated with convalescent plasma. Am. J. Case Rep. 21, (2020).","DOI":"10.12659\/AJCR.927812"},{"key":"34033_CR10","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1182\/blood.2020008423","volume":"136","author":"T Hueso","year":"2020","unstructured":"Hueso, T. et al. Convalescent plasma therapy for B-cell\u2013depleted patients with protracted COVID-19. Blood 136, 2290\u20132295 (2020).","journal-title":"Blood"},{"key":"34033_CR11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.21037\/apm.2019.11.27","volume":"9","author":"L Wei","year":"2020","unstructured":"Wei, L., Liu, B., Zhao, Y. & Chen, Z. Prolonged shedding of SARS-CoV-2 in an elderly liver transplant patient infected by COVID-19: a case report. Ann. Palliat. Med. 9, 8\u20138 (2020).","journal-title":"Ann. Palliat. Med."},{"key":"34033_CR12","doi-asserted-by":"publisher","first-page":"102871","DOI":"10.1016\/j.transci.2020.102871","volume":"59","author":"A Karata\u015f","year":"2020","unstructured":"Karata\u015f, A. et al. Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma. Transfus. Apher. Sci. 59, 102871 (2020).","journal-title":"Transfus. Apher. Sci."},{"key":"34033_CR13","first-page":"2021","volume":"1033","author":"CY Lee","year":"2021","unstructured":"Lee, C. Y. et al. Prolonged SARS-CoV-2 infection in patients with lymphoid malignancies. Cancer Discov. candisc 1033, 2021 (2021).","journal-title":"Cancer Discov. candisc"},{"key":"34033_CR14","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1111\/bjh.17266","volume":"192","author":"A Betrains","year":"2021","unstructured":"Betrains, A. et al. Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus\u20102 (SARS\u2010CoV\u20102) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies. Br. J. Haematol. 192, 1100\u20131105 (2021).","journal-title":"Br. J. Haematol."},{"key":"34033_CR15","doi-asserted-by":"publisher","first-page":"5212","DOI":"10.1016\/j.jmb.2020.07.009","volume":"432","author":"J Chen","year":"2020","unstructured":"Chen, J., Wang, R., Wang, M. & Wei, G.-W. Mutations Strengthened SARS-CoV-2 Infectivity. J. Mol. Biol. 432, 5212\u20135226 (2020).","journal-title":"J. Mol. Biol."},{"key":"34033_CR16","doi-asserted-by":"publisher","unstructured":"Peacock, T. P. et al. The furin cleavage site of SARS-CoV-2 spike protein is a key determinant for transmission due to enhanced replication in airway cells. https:\/\/doi.org\/10.1101\/2020.09.30.318311 (2020).","DOI":"10.1101\/2020.09.30.318311"},{"key":"34033_CR17","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.abf9302","volume":"371","author":"TN Starr","year":"2021","unstructured":"Starr, T. N. et al. Prospective mapping of viral mutations that escape antibodies used to treat COVID-19. Science 371, 850\u2013854 (2021).","journal-title":"Science"},{"key":"34033_CR18","doi-asserted-by":"publisher","unstructured":"Garrett, M. E. et al. High resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies. Cell S0092867421005808 https:\/\/doi.org\/10.1016\/j.cell.2021.04.045 (2021).","DOI":"10.1016\/j.cell.2021.04.045"},{"key":"34033_CR19","doi-asserted-by":"publisher","first-page":"641900","DOI":"10.3389\/fimmu.2021.641900","volume":"12","author":"M Shkurnikov","year":"2021","unstructured":"Shkurnikov, M. et al. Association of HLA class I genotypes with severity of coronavirus disease-19. Front. Immunol. 12, 641900 (2021).","journal-title":"Front. Immunol."},{"key":"34033_CR20","doi-asserted-by":"publisher","first-page":"565730","DOI":"10.3389\/fimmu.2020.565730","volume":"11","author":"MAM Pretti","year":"2020","unstructured":"Pretti, M. A. M. et al. Class I HLA allele predicted restricted antigenic coverages for spike and nucleocapsid proteins are associated with deaths related to COVID-19. Front. Immunol. 11, 565730 (2020).","journal-title":"Front. Immunol."},{"key":"34033_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.cels.2020.08.011","volume":"11","author":"CAM La Porta","year":"2020","unstructured":"La Porta, C. A. M. & Zapperi, S. Estimating the binding of Sars-CoV-2 peptides to HLA Class I in human subpopulations using artificial neural networks. Cell Syst. 11, 412\u2013417.e2 (2020).","journal-title":"Cell Syst."},{"key":"34033_CR22","doi-asserted-by":"publisher","first-page":"eabg6461","DOI":"10.1126\/sciimmunol.abg6461","volume":"6","author":"B Agerer","year":"2021","unstructured":"Agerer, B. et al. SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8 + T cell responses. Sci. Immunol. 6, eabg6461 (2021).","journal-title":"Sci. Immunol."},{"key":"34033_CR23","doi-asserted-by":"publisher","unstructured":"Dolton, G. et al. Emergence of immune escape at dominant SARS-CoV-2 killer T-cell epitope. https:\/\/doi.org\/10.1101\/2021.06.21.21259010 (2021).","DOI":"10.1101\/2021.06.21.21259010"},{"key":"34033_CR24","doi-asserted-by":"publisher","unstructured":"Tarke, A. et al. Negligible impact of SARS-CoV-2 variants on CD4 + and CD8 + T cell reactivity in COVID-19 exposed donors and vaccinees.https:\/\/doi.org\/10.1101\/2021.02.27.433180 (2021).","DOI":"10.1101\/2021.02.27.433180"},{"key":"34033_CR25","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1097\/QAD.0b013e32835e1616","volume":"27","author":"C Bronke","year":"2013","unstructured":"Bronke, C. et al. HIV escape mutations occur preferentially at HLA-binding sites of CD8 T-cell epitopes. AIDS 27, 899\u2013905 (2013).","journal-title":"AIDS"},{"key":"34033_CR26","doi-asserted-by":"publisher","first-page":"e1000365","DOI":"10.1371\/journal.ppat.1000365","volume":"5","author":"RM Troyer","year":"2009","unstructured":"Troyer, R. M. et al. Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response. PLoS Pathog. 5, e1000365 (2009).","journal-title":"PLoS Pathog."},{"key":"34033_CR27","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/35085576","volume":"412","author":"PJR Goulder","year":"2001","unstructured":"Goulder, P. J. R. et al. Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 412, 334\u2013338 (2001).","journal-title":"Nature"},{"key":"34033_CR28","doi-asserted-by":"publisher","first-page":"e1005111","DOI":"10.1371\/journal.ppat.1005111","volume":"11","author":"N Erdmann","year":"2015","unstructured":"Erdmann, N. et al. HLA Class-II associated HIV polymorphisms predict escape from CD4+ T cell responses. PLOS Pathog. 11, e1005111 (2015).","journal-title":"PLOS Pathog."},{"key":"34033_CR29","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S1074-7613(01)00245-X","volume":"15","author":"AL Erickson","year":"2001","unstructured":"Erickson, A. L. et al. The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity 15, 883\u2013895 (2001).","journal-title":"Immunity"},{"key":"34033_CR30","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.cell.2017.09.050","volume":"171","author":"R Marty","year":"2017","unstructured":"Marty, R. et al. MHC-I genotype restricts the oncogenic mutational landscape. Cell 171, 1272\u20131283.e15 (2017).","journal-title":"Cell"},{"key":"34033_CR31","doi-asserted-by":"publisher","first-page":"D339","DOI":"10.1093\/nar\/gky1006","volume":"47","author":"R Vita","year":"2019","unstructured":"Vita, R. et al. The Immune Epitope Database (IEDB): 2018 update. Nucleic Acids Res. 47, D339\u2013D343 (2019).","journal-title":"Nucleic Acids Res."},{"key":"34033_CR32","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.immuni.2020.10.006","volume":"53","author":"AP Ferretti","year":"2020","unstructured":"Ferretti, A. P. et al. Unbiased Screens Show CD8+ T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein. Immunity 53, 1095\u20131107.e3 (2020).","journal-title":"Immunity"},{"key":"34033_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22811-y","volume":"12","author":"A Gangaev","year":"2021","unstructured":"Gangaev, A. et al. Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features. Nat. Commun. 12, 2593 (2021).","journal-title":"Nat. Commun."},{"key":"34033_CR34","doi-asserted-by":"publisher","first-page":"eabf7550","DOI":"10.1126\/sciimmunol.abf7550","volume":"6","author":"SK Saini","year":"2021","unstructured":"Saini, S. K. et al. SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8 + T cell activation in COVID-19 patients. Sci. Immunol. 6, eabf7550 (2021).","journal-title":"Sci. Immunol."},{"key":"34033_CR35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/emmm.201100129","volume":"3","author":"IZ Mamedov","year":"2011","unstructured":"Mamedov, I. Z. et al. Quantitative tracking of T cell clones after haematopoietic stem cell transplantation. EMBO Mol. Med. 3, 201\u2013207 (2011).","journal-title":"EMBO Mol. Med."},{"key":"34033_CR36","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.humimm.2008.05.001","volume":"69","author":"OD Solberg","year":"2008","unstructured":"Solberg, O. D. et al. Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies. Hum. Immunol. 69, 443\u2013464 (2008).","journal-title":"Hum. Immunol."},{"key":"34033_CR37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41587-019-0322-9","volume":"38","author":"S Sarkizova","year":"2020","unstructured":"Sarkizova, S. et al. A large peptidome dataset improves HLA class I epitope prediction across most of the human population. Nat. Biotechnol. 38, 199\u2013209 (2020).","journal-title":"Nat. Biotechnol."},{"key":"34033_CR38","doi-asserted-by":"crossref","unstructured":"Peacock, T. P., Penrice-Randal, R., Hiscox, J. A. & Barclay, W. S. SARS-CoV-2 one year on: evidence for ongoing viral adaptation. J. Gen. Virol. 102 (2021).","DOI":"10.1099\/jgv.0.001584"},{"key":"34033_CR39","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","volume":"23","author":"P Moss","year":"2022","unstructured":"Moss, P. The T cell immune response against SARS-CoV-2. Nat. Immunol. 23, 186\u2013193 (2022).","journal-title":"Nat. Immunol."},{"key":"34033_CR40","doi-asserted-by":"publisher","first-page":"100354","DOI":"10.1016\/j.xcrm.2021.100354","volume":"2","author":"KW Cohen","year":"2021","unstructured":"Cohen, K. W. et al. Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells. Cell Rep. Med 2, 100354 (2021).","journal-title":"Cell Rep. Med"},{"key":"34033_CR41","doi-asserted-by":"publisher","unstructured":"Khatamzas, E. et al. CD8 T cells and antibodies drive SARS-CoV-2 evolution in chronic infection. https:\/\/www.researchsquare.com\/article\/rs-846197\/v1https:\/\/doi.org\/10.21203\/rs.3.rs-846197\/v1 (2021).","DOI":"10.21203\/rs.3.rs-846197\/v1"},{"key":"34033_CR42","doi-asserted-by":"publisher","unstructured":"Tyson, J. R. et al. Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore. https:\/\/doi.org\/10.1101\/2020.09.04.283077 (2020).","DOI":"10.1101\/2020.09.04.283077"},{"key":"34033_CR43","doi-asserted-by":"publisher","first-page":"e0239403","DOI":"10.1371\/journal.pone.0239403","volume":"15","author":"K Itokawa","year":"2020","unstructured":"Itokawa, K., Sekizuka, T., Hashino, M., Tanaka, R. & Kuroda, M. Disentangling primer interactions improves SARS-CoV-2 genome sequencing by multiplex tiling PCR. PLoS ONE 15, e0239403 (2020).","journal-title":"PLoS ONE"},{"key":"34033_CR44","doi-asserted-by":"crossref","unstructured":"Kawaguchi, S. & Matsuda, F. High-Definition Genomic Analysis of HLA Genes Via Comprehensive HLA Allele Genotyping. in Immunoinformatics (ed. Tomar, N.) vol. 2131 31\u201338 (Springer US, 2020).","DOI":"10.1007\/978-1-0716-0389-5_3"},{"key":"34033_CR45","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1093\/bioinformatics\/btz875","volume":"36","author":"E Geffard","year":"2020","unstructured":"Geffard, E. et al. Easy-HLA: a validated web application suite to reveal the full details of HLA typing. Bioinformatics 36, 2157\u20132164 (2020).","journal-title":"Bioinformatics"},{"key":"34033_CR46","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"34033_CR47","unstructured":"Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. ArXiv13033997 Q-Bio (2013)."},{"key":"34033_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-018-1618-7","volume":"20","author":"ND Grubaugh","year":"2019","unstructured":"Grubaugh, N. D. et al. An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar. Genome Biol. 20, 8 (2019).","journal-title":"Genome Biol."},{"key":"34033_CR49","doi-asserted-by":"publisher","first-page":"11189","DOI":"10.1093\/nar\/gks918","volume":"40","author":"A Wilm","year":"2012","unstructured":"Wilm, A. et al. LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets. Nucleic Acids Res. 40, 11189\u201311201 (2012).","journal-title":"Nucleic Acids Res."},{"key":"34033_CR50","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1093\/bioinformatics\/btr509","volume":"27","author":"H Li","year":"2011","unstructured":"Li, H. A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data. Bioinformatics 27, 2987\u20132993 (2011).","journal-title":"Bioinformatics"},{"key":"34033_CR51","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The sequence alignment\/map format and SAMtools. Bioinforma. Oxf. Engl. 25, 2078\u20132079 (2009).","journal-title":"Bioinforma. Oxf. Engl."},{"key":"34033_CR52","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/molbev\/mst010","volume":"30","author":"K Katoh","year":"2013","unstructured":"Katoh, K. & Standley, D. M. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol. Biol. Evol. 30, 772\u2013780 (2013).","journal-title":"Mol. Biol. Evol."},{"key":"34033_CR53","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"F Wu","year":"2020","unstructured":"Wu, F. et al. A new coronavirus associated with human respiratory disease in China. Nature 579, 265\u2013269 (2020).","journal-title":"Nature"},{"key":"34033_CR54","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/s41564-020-0770-5","volume":"5","author":"A Rambaut","year":"2020","unstructured":"Rambaut, A. et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat. Microbiol. 5, 1403\u20131407 (2020).","journal-title":"Nat. Microbiol."},{"key":"34033_CR55","unstructured":"Sergei Pond. Evolutionary annotation of global SARS-CoV-2\/COVID-19 genomes enabled by data from GISAID. observablehq.com (2020)."},{"key":"34033_CR56","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/molbev\/msu300","volume":"32","author":"L-T Nguyen","year":"2015","unstructured":"Nguyen, L.-T., Schmidt, H. A., von Haeseler, A. & Minh, B. Q. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol. Biol. Evol. 32, 268\u2013274 (2015).","journal-title":"Mol. Biol. Evol."},{"key":"34033_CR57","doi-asserted-by":"crossref","unstructured":"Sagulenko, P., Puller, V. & Neher, R. A. TreeTime: Maximum-likelihood phylodynamic analysis. Virus Evol. 4, (2018).","DOI":"10.1093\/ve\/vex042"},{"key":"34033_CR58","doi-asserted-by":"publisher","first-page":"e9490","DOI":"10.1371\/journal.pone.0009490","volume":"5","author":"MN Price","year":"2010","unstructured":"Price, M. N., Dehal, P. S. & Arkin, A. P. FastTree 2 \u2013 Approximately Maximum-Likelihood Trees for Large Alignments. PLoS ONE 5, e9490 (2010).","journal-title":"PLoS ONE"},{"key":"34033_CR59","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","volume":"48","author":"B Reynisson","year":"2020","unstructured":"Reynisson, B., Alvarez, B., Paul, S., Peters, B. & Nielsen, M. NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res. 48, W449\u2013W454 (2020).","journal-title":"Nucleic Acids Res."},{"key":"34033_CR60","unstructured":"R. Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, (2018)."},{"key":"34033_CR61","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1467-985X.2010.00676_9.x","volume":"174","author":"C Ginestet","year":"2011","unstructured":"Ginestet, C. ggplot2: Elegant Graphics for Data Analysis: Book Reviews. J. R. Stat. Soc. Ser. A Stat. Soc. 174, 245\u2013246 (2011).","journal-title":"J. R. Stat. Soc. Ser. A Stat. Soc."},{"key":"34033_CR62","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/bioinformatics\/btl529","volume":"23","author":"I Letunic","year":"2007","unstructured":"Letunic, I. & Bork, P. Interactive Tree Of Life (iTOL): an online tool for phylogenetic tree display and annotation. Bioinforma. Oxf. Engl. 23, 127\u2013128 (2007).","journal-title":"Bioinforma. Oxf. Engl."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34033-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34033-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34033-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T13:05:23Z","timestamp":1673355923000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34033-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["34033"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-34033-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-750741\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]},"assertion":[{"value":"24 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"149"}}